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Introduction
Neuronal activity within the basolateral nucleus of the amygdala (BLA) is thought to play an integral role in the regulation of anxiety-like behaviors (LeDoux, 2003) . Numerous studies have shown that microinjection of GABA A receptor agonists directly into the BLA can produce anxiolytic effects in a number of behavioral paradigms, while microinjection of GABA A receptor antagonists into the BLA can produce increases in some anxiety-like behaviors (for reviews see: (Menard and Treit, 1999; Engin and Treit, 2008) . Moreover, local infusion of a GABA A receptor antagonist into the BLA can block the anxiolytic effects of a systemically administered benzodiazepine (Sanders and Shekhar, 1995) , clearly demonstrating the significance of BLA GABAergic tone in the regulation of anxiety behaviors. Interestingly, ethanol (EtOH) has been shown to enhance GABAergic transmission in many brain regions (Siggins et al., 2005; Breese et al., 2006; Weiner and Valenzuela, 2006) and acute EtOH administration has also been shown to produce anxiolytic effects in a wide range of behavioral paradigms (Tornatzky and Miczek, 1995; Langen et al., 2002; Chandra et al., 2008) , suggesting that EtOH potentiation of BLA GABAergic transmission may contribute to the anxiolytic effects of this drug. Notably, the relief of stress and anxiety brought on by acute EtOH consumption is thought to play an integral role in the development and progression of alcohol use disorders (Koob and Le Moal, 2005; Sinha et al., 2008; Uhart and Wand, 2009; Breese et al., 2011) . Therefore, determining the mechanism(s) through which EtOH enhances GABAergic synapses in the BLA may shed new light on our understanding of the cellular and synaptic events involved in the etiology of alcoholism.
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arises from the diverse groups of local circuit GABAergic interneurons that mainly provide feedback inhibition within the BLA (Woodruff and Sah, 2007) . The second pathway arises from a distinct class of GABAergic cells that reside along the border between the BLA and the external capsule. These lateral paracapsular (LPCS) cells are thought to provide cortical feed-forward inhibition to the BLA (Marowsky et al., 2005) . Initial studies have demonstrated that EtOH enhances both local and LPCS GABAergic inhibition, albeit via distinct mechanisms. EtOH enhances local GABAergic synapses via a presynaptic facilitation of GABA release, as observed in a number of other brain regions (Weiner and Valenzuela, 2006) . In contrast, EtOH enhancement of the LPCS-mediated pathway appears to be mediated via a novel mechanism that may involve postsynaptic adrenergic receptor (AR) activation (Silberman et al., 2008) .
Interestingly, the BLA receives strong innervation by noradrenergic (NE) afferents, which mainly enter the BLA as dense bundles via the external capsule (Fallon et al., 1978) . Based on their similar anatomical location, it is likely that NE afferents may modulate LPCS inhibition and potentially regulate EtOH potentiation of these synapses. This hypothesis is directly supported by our initial evidence that exogenous NE can enhance LPCS evoked IPSCs (eIPSCs) and that antagonism of ARs can block EtOH enhancement of LPCS GABAergic transmission (Silberman et al., 2008) . Therefore, the purpose of this study was three fold: 1) to further characterize the effect of NE on LPCS GABAergic inhibition in the BLA; 2) to determine how the NE system modulates EtOH potentiation of LPCS synapses; 3) to identify the AR subtype(s) responsible for these effects. Our data suggest that NE enhances LPCS GABAergic inhibition in the BLA through a -AR dependent mechanism and that EtOH potentiation of LPCS GABAergic transmission is dependent on postsynaptic β1-AR activation.
JEPT #196022 6 Methods Slice preparation. Transverse amygdala slices (400 µm) were prepared from 4-to 6-week-old male Sprague-Dawley rats. Slices were maintained at ambient temperature for at least 1 hr in oxygenated artificial cerebrospinal fluid (aCSF) containing (in mM): 124 NaCl, 3.3 KCl, 2.4 MgCl 2 , 2.5 CaCl 2 , 1.2 KH 2 PO 4 , 10 D-glucose, and 25 NaHCO 3 , saturated with 95% O 2 and 5% CO 2 .
Electrophysiological recordings. Slices were transferred to a recording chamber and superfused with aerated aCSF at 2 ml/min using a calibrated flowmeter (Gilmont Instruments, Racine, WI).
Experiments were performed at ambient temperature as our previous studies have found that this promotes the stability of patch-clamp recordings in brain slices and does not influence EtOH enhancement of GABA A IPSCs (Ariwodola and Weiner, 2004; Silberman et al., 2008) .
Recording electrodes were prepared from filamented borosilicate glass capillary tubes (inner diameter, 0.86 mm) using a horizontal micropipette puller (P-97; Sutter Instruments, Novato, CA). Whole-cell patch-clamp recordings of evoked IPSCs (eIPSCs) were made using a "standard" filling solution containing 130 mM K-gluconate, 10 mM KCl, 1 mM EGTA, 100 µM CaCl 2 , 2 mM Mg-ATP, 200 µM Tris-guanosine 5'-triphosphate, and 10 mM HEPES, pH adjusted with KOH, 275-280 mOsm. In some experiments, 40 M Rp-CAMPS or 20 µM PKA inhibitor fragment (6-22) amide (PKA-I) were added to the standard solution to disrupt postsynaptic cAMP signaling. Recordings of spontaneous IPSCs (sIPSCs) were made using a similar filling solution, exchanging equimolar CsCl for K-gluconate and KCl. In all experiments, 5 mM N-(2,6-dimethyl-phenylcarbamoylmethyl)-triethylammonium chloride (QX-314) was included in the recording solution to block voltage-gated sodium currents and the postsynaptic K + conductance underlying GABA B IPSCs in the BLA neurons being recorded JEPT #196022 (Horn et al., 1980; Nathan et al., 1990 
Results
NE pretreatment significantly occludes EtOH potentiation of LPCS synapses
Previous work from our lab suggests that exogenous NE can significantly enhance LPCS eIPSCs; an effect that is blocked by a cocktail of 1, 2, and -AR antagonists. Moreover, EtOH potentiation of LPCS, but not local, eIPSCs was also blocked by this same AR antagonist cocktail (Silberman et al., 2008) , suggesting that the effect of EtOH at LPCS synapses involves 
 -ARs contribute to both NE and EtOH potentiation of LPCS eIPSCs
Our previous work showed that NE-mediated enhancement of LPCS eIPSCs can be blocked by a cocktail 1, 2, and -AR antagonists. In order to better ascertain which AR subtype(s) was responsible for the effect of NE, we treated BLA slices with modified AR antagonist cocktails, in which individual antagonists were removed, and then examined the effect of NE. We found that treating BLA slices with just 10 M propranolol, a non-selective -AR antagonist that had no effect on its own (1.7±4.7% increase from control, n= 7), significantly reduced the potentiating effect of 20 M NE on LPCS eIPSCs by almost 73% (15.3±10.5%
increase from control, n= 3, p< 0.05 vs NE alone; Fig 3) . These findings suggest that NE potentiation of LPCS eIPSCs is mediated by β-AR activation.
Since NE pretreatment significantly occluded EtOH potentiation of LPCS eIPSCs and NE potentiation of LPCS inhibition was blocked by propranolol, we next tested the hypothesis that -ARs may also regulate the effects of EtOH on LPCS eIPSC. To test this hypothesis, BLA slices were treated with 10 M propranolol for 8-10 minutes, followed by application of 80 mM
EtOH for 8-10 minutes. Propranolol treatment significantly reduced EtOH potentiation of LPCS eIPSCs by almost 92% (4.5±6.0% increase from control, n= 7, p< 0.05 vs EtOH alone, Fig 3) ,
suggesting that -AR activation is required for EtOH potentiation of LPCS synapses.
 -ARs do not alter the facilitatory effects of EtOH on sIPSCs
We have previously shown that EtOH enhances the frequency of sIPSCs and TTXresistant miniature IPSCs recorded from BLA pyramidal neurons without altering the kinetics of these events, consistent with a presynaptic facilitation of GABA release (Silberman et al, 2009 ).
Additionally, the facilitatory effect of EtOH on sIPSC frequency was significantly enhanced by a GABA B receptor antagonist and blocked by pretreatment with a GABA B receptor agonist, consistent with the effects of these modulators on EtOH enhancement of local, but not LPCS, eIPSCs (Silberman et al., 2009 increases from control, respectively, n= 8,). Bath application of 10 M propranolol for 8-10 minutes had no effect on the frequency, amplitude or decay of sIPSCs (14.2±23.7%, 9.4±15.7%, and 8.5±3.8% increases from control, respectively, n= 5). Following propranolol treatment, application of 80 mM EtOH still resulted in a significant increase in sIPSC frequency (84.2±23.3% increase from propranolol levels n= 6, p< 0.05; Fig 4) with no, significant change in the amplitude or decay of these events (19.3±9.3% and 11.4±6.5% increases, respectively, n= 6, Fig 4) . Importantly, there was no significant difference in the magnitude of EtOH enhancement of sIPSC frequency between control and propranolol pretreatment conditions, further suggesting that LPCS synapses do not significantly contribute to sIPSC activity under our recording conditions.
 1-AR activation is required for EtOH potentiation of LPCS eIPSCs
Recent research has shown that functional 1, 2, and 3-ARs may be present in the BLA (Abraham et al., 2008; Silberman et al.2010 ). Since propranolol is a non-selective -AR antagonist which can potentially block all three -AR subtypes at the concentration used in this study (Hoffmann et al., 2004) , we next sought to determine which -AR subtype(s) might be responsible for the potentiating effects of EtOH on LPCS eIPSCs.
To that end, we tested the effect of various -AR subtype selective antagonists on EtOH potentiation of LPCS eIPSCs.
Experiments examining the effect of 80 mM EtOH alone were interspersed throughout these Fig 5) which was not significantly different from the effect EtOH described earlier (Fig 1) .
Bath application of a selective 1-AR antagonist, 1 M CGP20712A (CGP), for 8-10 minutes had no effect of LPCS eIPSC area (2.9±20.1% increase from control, n= 4, Fig 5) .
However, CGP pretreatment significantly attenuated EtOH potentiation of LPCS eIPSCs (21.1±8.8% increase from CGP levels, n= 7, Fig 5) , suggesting that a significant portion of the facilitatory effects of EtOH at LPCS GABAergic synapses involves the activation of 1-ARs.
Similar experiments were performed with either a selective 2-AR antagonist (1M ICI118,551)
or a selective 3-AR antagonist (4M SR59230A). Bath application of either antagonist alone had no significant effect on LPCS eIPSC area (9.4±6.8% and 4.3±6.1% decreases from baseline, n= 6 and 7, respectively) and also had no significant effect on EtOH potentiation of LPCS eIPSCs (42.8±9.8% and 88.0±22.1% increase from pretreatment levels, p<0.05 vs pretreatment levels, n=8 and 6, respectively, Fig 5) 
Synaptic locus of EtOH potentiation of LPCS synapses
Together, the above findings suggest that -AR activation is required for NE and EtOH potentiation of LPCS eIPSCs, with the 1-AR subtype playing a predominant role in mediating EtOH facilitation. We next sought to examine the synaptic locus underlying these effects as prior studies suggested that EtOH enhancement of LPCS IPSCs was not dependent on an increase in terminal GABA release (Silberman et al., 2008 (Silberman et al., , 2009 Fig 6) .
We next conducted a similar series of experiments to assess the effect of cAMP signaling on EtOH potentiation of LPCS eIPSCs. 80 mM EtOH significantly potentiated the area of LPCS eIPSCs using a standard recording solution (82.3±18.2%, increase from baseline, p<0.05, n=9).
In comparison, inclusion of Rp-CAMPS into the recording solution significantly reduced the potentiating effect of 80 mM EtOH (16.2±7.4% increase from baseline, n= 7; Rp-CAMPS vs interspersed control p< 0.05, Fig 7A,C ). There were no significant differences in the effects of 20 µM NE or 80 mM EtOH during the interspersed control experiments compared to the effects of these modulators described in earlier experiments throughout this manuscript.
As an additional control, we also examined the effect of Rp-CAMPS on EtOH potentiation of locally evoked GABA A IPSCs. As predicted from our prior work demonstrating 82.3±12.1%, n=7, data not shown).
Finally, although Rp-CAMPS was only present in the patch pipette, this compound can diffuse across cellular membranes. To control for the possibility that this drug may have inhibited EtOH potentiation of LPCS IPSCs by diffusion to presynaptic loci, we repeated the same experimental protocol using a membrane impermeant peptide inhibitor of PKA (PKA-I).
Inclusion of 20 µM PKA-I in the recording solution also blocked EtOH enhancement of LPCS IPSCS (19.0±7.0%, n=9) (Fig 7B,C) .
Discussion
The results of this study confirm and expand upon our previous findings that EtOH and NE enhance LPCS eIPSCs in the rat BLA (Silberman et al., 2008) . NE pretreatment significantly occluded EtOH potentiation of LPCS inhibition and the potentiating effects of EtOH and NE on LPCS eIPSCs were significantly decreased by the non-selective -AR antagonist, propranolol. Furthermore, EtOH facilitation of LPCS synapses required 1-AR activation while disruption of postsynaptic cAMP signaling significantly reduced the potentiating effects of both EtOH and NE on LPCS eIPSCs. In contrast, propranolol did not block EtOHinduced increases in sIPSC frequency, a measure of local, and not LPCS, GABAergic interneuron activity under our recording conditions (Silberman et al., 2009 ) and postsynaptic inhibition of cAMP signaling had no effect on EtOH enhancement of local eIPSCs, suggesting dissociable effects of EtOH at distinct inhibitory synapses onto BLA pyramidal neurons.
This article has not been copyedited and formatted. The final version may differ from this version. (Asan, 1998) and at least some of these projections target the external capsule region that was stimulated to evoke LPCS EPSCs (Fuxe et al., 2003) . While no studies, to date, have directly examined the acute effects of EtOH on NE release in brain slice preparations, there is considerable evidence from in vivo studies that plasma NE levels are increased following EtOH exposure in both rats (Patterson-Buckendahl et al., 2005) and humans (Patkar et al., 2004) and that acute EtOH treatments stimulate NE circuitry in the CNS (Lee et al., 2011) . Additionally, studies with dopamine -hydroxylase knockout mice, the key enzyme involved in NE synthesis, show that NE plays an integral role in EtOH preference and consumption (Weinshenker et al., 2000) and inhibition of -ARs significantly reduces dependence-induced increases in EtOH self-administration in rats (Gilpin and Koob, 2010) . Further studies will be needed to discern how -AR activation regulates EtOH actions at LPCS synapses, however our findings suggest that these synapses may represent an important locus that contributes to some of the behaviorally relevant EtOH-NE interactions that have been reported in vivo.
To ascertain which -AR subtype might be required for EtOH enhancement of LPCS eIPSCs, we tested the effect of -AR subtype-selective antagonists. Based on prior findings by us, and others, demonstrating that 3-AR activation in the BLA selectively enhances LPCS This article has not been copyedited and formatted. The final version may differ from this version.
JPET Fast Forward. Published on August 17, 2012 as DOI: 10.1124 at ASPET Journals on July 9, 2017 jpet.aspetjournals.org Downloaded from eIPSCs (Silberman et al., 2010) and that systemic administration (Stemmelin et al., 2008) or intra-BLA infusion (Silberman et al., 2010 ) of a 3-AR agonist decreases anxiety-like behaviors, we hypothesized that this AR subtype might mediate EtOH actions at LPCS synapses.
Surprisingly, our findings indicate that 1-ARs play the predominant role in mediating EtOH enhancement of LPCS synapses while blockade of 3-ARs had no discernible effect on EtOH enhancement of these responses. While the density of -AR subtypes in the BLA has yet to be determined, 2-and3-ARs are likely expressed at lower levels than -ARs in this brain region (Rainbow et al., 1984; Abraham et al., 2008) . In addition, 1-ARs are thought to have a higher affinity for NE than 2-or 3-ARs (Molinoff, 1984; Wallukat, 2002) . Therefore, if EtOH does indeed act by increasing NE release, it seems plausible that endogenous NE may act predominantly on 1-ARs in the BLA. However, it is worth noting that repeated EtOH exposure as well as stress can profoundly influence GABAergic circuitry and AR function in the BLA (Braga et al., 2004; Buffalari and Grace, 2009; Diaz et al., 2011) . Therefore, it will be important in future studies to more thoroughly characterize the contribution of all three -AR subtypes in regulating in vitro and in vivo effects of EtOH, particularly following chronic exposure and withdrawal from this drug.
To more thoroughly characterize the mechanisms of EtOH action at local and LPCS inhibitory synapses in the BLA, we first tested the effect of propranolol pretreatment on EtOH modulation of sIPSCs. We have previously shown that EtOH significantly increases sIPSC frequency and that GABA B receptor modulators can alter this effect in a manner similar to the effect of these modulators on EtOH potentiation of local IPSCs (Silberman et al., 2009 ). These findings, coupled with the putative distal dendritic origin of LPCS synapses, suggest that sIPSCs largely reflect local interneuron activity in the BLA, at least under our recording conditions. This article has not been copyedited and formatted. The final version may differ from this version.
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However, if LPCS cells significantly contribute as a source of sIPSCs, then propranolol pretreatment should reduce EtOH enhancement of sIPSC frequency. Our data reveal that EtOH significantly enhanced the frequency of sIPSCs and that this effect was not attenuated by propranolol pretreatment. These findings provide further evidence that LPCS interneurons are not a significant source of sIPSCs in brain slice experiments. In addition, we also found that selective disruption of postsynaptic cAMP signaling, by inclusion of Rp-CAMPS or a membrane impermeant peptide inhibitor of PKA (PKA-I) into the patch pipette recording solution, significantly reduced NE and EtOH potentiation of LPCS eIPSCs. In contrast, disruption of cAMP signaling had no effect on EtOH enhancement of local eIPSCs. Together, these findings provide further evidence that EtOH potentiation of LPCS eIPSCs is mediated by a postsynaptic mechanism that requires activation of 1-ARs and the subsequent initiation of cAMP signaling cascades.
It is somewhat surprising that exogenous NE alone could enhance LPCS eIPSCs. NE is thought to play an integral role in the physiological response to stress and anxiety (Morilak et al., 2005) . It is generally thought that NE released during times of stress acts to enhance neuronal excitation in target brain regions (Bremner et al., 1996) . Since BLA activation plays an integral role in the regulation of anxiety behaviors, and since NE is thought to increase CNS excitation in response to anxious stimuli, it has been generally accepted that NE increases BLA excitability.
Indeed, activation of 1-2 ARs can increase excitatory synaptic transmission in the BLA (Abraham et al., 2008; Silberman et al., 2010) . Such an effect could serve as a cellular mechanism for enhanced anxiety-like behaviors in the face of external stressors. However, in this study we found that NE significantly enhances LPCS-mediated IPSCs, an effect that would be expected to decrease BLA excitability. Indeed, selective enhancement of LPCS GABAergic
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transmission in vivo is sufficient to decrease experimental measures of anxiety-like behavior (Silberman 2010) . It is also worth noting that NE can enhance BLA GABA release via an 1-AR mediated mechanism which increases the firing rate of local interneurons (Braga et al., 2004; Kaneko et al., 2008) . Importantly, in vivo electrophysiological evidence suggests that NE can both enhance and depress the excitability of BLA neurons (Buffalari and Grace, 2007; Chen and Sara, 2007) .
One emerging hypothesis from this collective body of evidence may be that NE modulation of emotional behaviors, like anxiety, arises via an equilibrated balance between the excitatory and inhibitory effects of this neurotransmitter on BLA excitability. Interestingly, chronic stressors have been shown to reduce the ability of NE to increase BLA GABAergic tone (Braga et al., 2004) and decrease BLA excitability (Buffalari and Grace, 2009 ) whereas stress may actually sensitize excitatory effects of NE in this brain region (Buffalari and Grace, 2009 ).
These data suggest that some of the inhibitory effects of NE on BLA excitability may become uncoupled following chronic stress while NE influences on BLA excitatory transmission may remain unchanged or even grow more pronounced. These findings raise the intriguing possibility that an imbalance between the normal excitatory and inhibitory actions of NE within the BLA may contribute to the etiology of anxiety-related disorders by tipping the scales toward increased BLA excitability. Furthermore, numerous reports have shown that withdrawal from chronic intermittent EtOH (CIE) exposure results in pronounced increases in anxiety-like behaviors (for review see: Kliethermes, 2005; McCool et al., 2010) . In addition, cycles of chronic stress can substitute for cycles of CIE exposure (Knapp et al., 2007) . Therefore, it also seems possible that chronic EtOH exposure may disrupt inhibitory effects of NE in the BLA and thus contribute to the progressive increase in anxiety associated with alcohol abuse disorders. In
JPET Fast Forward. Published on August 17, 2012 as DOI: 10.1124 at ASPET Journals on July 9, 2017 jpet.aspetjournals.org Downloaded from fact, propranolol significantly attenuates dependence-induced increases in EtOH selfadministration in rats while having no effect on drinking in non-dependent animals (Gilpin and Koob, 2010) .
In summary, our findings suggest that EtOH potentiation of LPCS GABAergic transmission may be mediated via a postsynaptic mechanism that requires activation of -ARs and the subsequent initiation of cAMP signaling cascades. Since enhancement of LPCS inhibition is sufficient to decrease at least some measures of anxiety-like behavior, these findings identify a novel mechanism that likely contributes to some of the anxiolytic effects of EtOH that are thought to play an integral role in the etiology of alcohol use disorders.
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